Search

This study reports the identification of the CMF1 protein in somites and embryonic limb muscle. We have previously described CMF1 in developing cardiac muscle. CMF1 is a member of the LEK family of proteins, which are involved in regulating mitosis. Our current data suggest that CMF1 expressed in skeletal and cardiac myocytes is the product of a single gene and that the two proteins are homologous or very highly conserved. Immunohistochemistry shows a dynamic subcellular localization of CMF1 in differentiating skeletal myoblasts: Early myoblasts stain positively for CMF1 antigen in the nucleus, while differentiating myoblasts stain positively in the cytoplasm. CMF1 expression precedes myosin. Later, CMF1 and myosin are detected in the cytoplasm of the same cells. Transfection analysis identifies a functional nuclear localization signal (NLS) in CMF1, whose nuclear transport capability is modified by external sequences. To characterize the function of CMF1 in skeletal muscle, we used antisense oligonucleotides to disrupt CMF1 in myoblast cultures. Expression of CMF1 in early myotubes is reduced by an average of 40% on a cell by cell basis, with a 56% reduction in anti-myosin staining. These data suggest that CMF1 is involved in induction and/or accumulation of myosin in differentiating myocytes., (Copyright 2000 Wiley-Liss, Inc.)

Disruption of the CMF1 function in anterior mesoderm inhibits cardiac myogenesis in avian embryos. In the present study, we show that CMF1 is a member of an emerging family of proteins that includes centromeric protein-F, mitosin, and LEK1. These proteins are characterized by their large size (350 kDa), dynamic subcellular distribution, and potential functions in cell division and differentiation. The current data suggest that CMF1 is a unique member of this family by virtue of its restricted protein expression and variant subcellular distribution. Immunochemical analysis demonstrates that CMF1 protein is expressed in cardiogenic cells prior to the activation of cardiac structural gene products. In addition, we show that expression of CMF1 is not dependent on the bone morphogenetic protein (BMP) signaling pathway during development. Still, CMF1 cannot direct cardiomyogenesis in the absence of such factors as NKX-2.5. Taken with our previous data, this study suggests that CMF1 is a BMP-independent component of the cardiomyogenic pathway.

The organization and sequence of genes encoding the alpha 1-proteinase inhibitor (alpha 1PI), a major serine proteinase inhibitor of the mammalian bloodstream, have been compared in several species, including murine rodents (genus Mus). Analysis of gene copy number indicates that amplification of alpha 1PI genes occurred at some time during evolution of the Mus genus, leading to fixation of a family of about three to five genes in several existing species (e.g., M. domesticus and M. saxicola), and only a single gene in others (e.g., M. caroli). A phylogeny for the various mammalian alpha 1PI mRNAs was constructed based upon synonymous substitutions within coding regions. The mRNAs in different murine species diverged from a common ancestor before the formation of the first species lineages of the Mus genus, i.e., about 10-13 million years ago. Thus, alpha 1PI gene amplification must have occurred prior to Mus speciation; gene families were retained in some, but not all, murine species. The reactive center region of the alpha 1PI polypeptide, which determines target protease specificity, has diverged rapidly during evolution of the Mus species, but not during evolution of other mammalian species included in the analysis. It is likely that this accelerated evolution of the reactive center, which has been noted previously for serine proteinase inhibitors, was driven by some sort of a positive Darwinian selection that was exerted in a taxon-specific manner. We suggest that evolution of alpha 1PI genes of murine rodents has been characterized by both modification of gene copy number and rapid reactive center divergence. These processes may have resulted in a broadened repertoire of proteinase inhibitors that was evolutionarily advantageous during Mus speciation.